Arcus Biosciences: Many Important Oncology Catalysts Coming Up In 2025 #Arcus #Biosciences #Important #Oncology #Catalysts #Coming
Tag: Biosciences
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York–(Newsfile Corp. – January 11, 2025) – WHY: Rosen Law Firm, a global…
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York–(Newsfile Corp. – January 10, 2025) – WHY: Rosen Law Firm, a global…
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development By Investing.com
Samsung (KS:) Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership…
Castle Biosciences director Bradbury sells shares worth $229,225 By Investing.com
Daniel Bradbury, a director at Castle Biosciences Inc . (NASDAQ:), reported the sale of company shares…
Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit By Investing.com
New York, New York–(Newsfile Corp. – January 5, 2025) – Bronstein, Gewirtz & Grossman, LLC, a…
Cytek Biosciences stock jumps on new $50M buyback plan By Investing.com
Investing.com — On Monday, shares of Cytek Biosciences experienced a notable uptick, climbing as high as…
Precision Biosciences director Melinda Brown acquires $13,722 in stock By Investing.com
Melinda Brown, a director at Precision BioSciences Inc . (NASDAQ:), recently increased her stake in the…
IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors
Exclusive global license outside of Greater China for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug…
Ventyx Biosciences’ chief scientific officer sells $29,682 in stock By Investing.com
John Nuss, the Chief Scientific Officer of Ventyx Biosciences, Inc. (NASDAQ:VTYX), recently sold shares of the…
Avidity Biosciences CHRO Teresa McCarthy sells $364,191 in stock By Investing.com
SAN DIEGO—Avidity Biosciences, Inc. (NASDAQ:RNA) Chief Human Resources Officer Teresa McCarthy recently sold shares of the…